Legal
Hot Development-stage Biotech Accused of Bad Behavior
|
A veterinarian and a scientist have been raising millions in capital through Midtown Partners with registered direct offerings for their public biotech company NanoViricides (NNVC). Another $10.3 million of stock in the $250 million market cap company, which was recently uplisted to the NYSE MKT, was sold to institutional investors in mid-September at a 26% discount to the closing price of the shares. But a group of early investors in the company has filed a shareholder derivative suit in Colorado federal court claiming company executives Anil Diwan and Eugene Seymour are abusing company assets and have breached their fiduciary duties. The investor group is led by Colorado resident Brian Brambell, who helped raise over $2.25 million of early seed money for Diwan and Seymour between 2007 and 2009. The company works on exploratory research to use plastic to attach to virus cells and expel them from the body.



